PB

Paul Berns

Managing Director at ARCH Venture Partners

Wisconsin

Investor
VC

Invests in

Stages:

Series B

Sectors:

Pharmaceuticals
BioTech
San Francisco Bay Area

Locations:

Wisconsin
Palo Alto, California
  • Min Investment:

    $50,000.00
  • Max Investment:

    $150,000,000.00
  • Target Investment:

    $25,000,000.00

Investments

Metsera

Series A

Total Funding: $290M

Matter Neuroscience

Seed

Total Funding: $26M

Areteia Therapeutics

Series A

Total Funding: $430M

HI-Bio

Series A

Total Funding: $220M

Elephas

Series B

Total Funding: $97M

Happy Health

Series A

Total Funding: $60M

Epirium Bio

Series A

Total Funding: $86M

BlackThorn Therapeutics

Series A

Total Funding: $130M

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.